Global law firm Greenberg Traurig P.A. advised OPKO Health Inc. in its acquisition of ModeX Therapeutics Inc., a privately-held biotechnology company, for $300 million in OPKO common stock this week.
(PRWeb May 23, 2022)
Read the full story at https://www.prweb.com/releases/greenberg_traurig_advises_opko_health_on_modex_therapeutics_acquisition_and_sale_of_genedx_unit/prweb18695991.htm